These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 27233502)

  • 21. Serum klotho protein levels and their correlations with the progression of type 2 diabetes mellitus.
    Nie F; Wu D; Du H; Yang X; Yang M; Pang X; Xu Y
    J Diabetes Complications; 2017 Mar; 31(3):594-598. PubMed ID: 27916483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A.
    Kacso IM; Bondor CI; Kacso G
    Clin Biochem; 2012 Nov; 45(16-17):1415-20. PubMed ID: 22836100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary RBP and NGAL Levels are Associated with Nephropathy in Patients with Type 2 Diabetes.
    Wu J; Shao X; Lu K; Zhou J; Ren M; Xie X; Liu J; Xu Y; Ding Y; Shen X; Zhu C
    Cell Physiol Biochem; 2017; 42(2):594-602. PubMed ID: 28954270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
    Nowak N; Skupien J; Smiles AM; Yamanouchi M; Niewczas MA; Galecki AT; Duffin KL; Breyer MD; Pullen N; Bonventre JV; Krolewski AS
    Kidney Int; 2018 May; 93(5):1198-1206. PubMed ID: 29398132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
    Shimoike T; Inoguchi T; Umeda F; Nawata H; Kawano K; Ochi H
    Metabolism; 2000 Aug; 49(8):1030-5. PubMed ID: 10954022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urine Albumin-Creatinine Ratio Variability in People With Type 2 Diabetes: Clinical and Research Implications.
    Rasaratnam N; Salim A; Blackberry I; Cooper ME; Magliano DJ; van Wijngaarden P; Varadarajan S; Sacre JW; Shaw JE
    Am J Kidney Dis; 2024 Jul; 84(1):8-17.e1. PubMed ID: 38551531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of serum levels of sestrin 2 and betatrophin in type 2 diabetic patients with diabetic nephropathy.
    Emara AM; El Bendary AS; Ahmed LM; Okda HI
    BMC Nephrol; 2024 Jul; 25(1):231. PubMed ID: 39030467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urine haptoglobin levels predict early renal functional decline in patients with type 2 diabetes.
    Bhensdadia NM; Hunt KJ; Lopes-Virella MF; Michael Tucker J; Mataria MR; Alge JL; Neely BA; Janech MG; Arthur JM;
    Kidney Int; 2013 Jun; 83(6):1136-43. PubMed ID: 23536133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maximum home blood pressure is a useful indicator of diabetic nephropathy in patients with type 2 diabetes mellitus: KAMOGAWA-HBP study.
    Oyabu C; Ushigome E; Matsumoto S; Tanaka T; Hasegawa G; Nakamura N; Ohnishi M; Tsunoda S; Ushigome H; Yokota I; Tanaka M; Asano M; Yamazaki M; Fukui M
    Diab Vasc Dis Res; 2017 Nov; 14(6):477-484. PubMed ID: 28819987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease.
    Sun AL; Deng JT; Guan GJ; Chen SH; Liu YT; Cheng J; Li ZW; Zhuang XH; Sun FD; Deng HP
    Diab Vasc Dis Res; 2012 Oct; 9(4):301-8. PubMed ID: 22388283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes.
    Chuahirun T; Khanna A; Kimball K; Wesson DE
    Am J Kidney Dis; 2003 Jan; 41(1):13-21. PubMed ID: 12500217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes.
    Jeon YK; Kim MR; Huh JE; Mok JY; Song SH; Kim SS; Kim BH; Lee SH; Kim YK; Kim IJ
    J Korean Med Sci; 2011 Feb; 26(2):258-63. PubMed ID: 21286018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of circulatory asymmetric dimethylarginine (ADMA) with diabetic nephropathy in Asian Indians and its causative role in renal cell injury.
    Jayachandran I; Sundararajan S; Paramasivam P; Venkatesan B; Subramanian SC; Balasubramanyam M; Mohan V; Manickam N
    Clin Biochem; 2017 Oct; 50(15):835-842. PubMed ID: 28495185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High urinary sulfate concentration is associated with reduced risk of renal disease progression in type 2 diabetes.
    van den Born JC; Frenay AR; Bakker SJ; Pasch A; Hillebrands JL; Lambers Heerspink HJ; van Goor H
    Nitric Oxide; 2016 May; 55-56():18-24. PubMed ID: 26952289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble tumor necrosis factor receptor type 1 is an alternative marker of urinary albumin-creatinine ratio and estimated glomerular filtration rate for predicting the decline of renal function in subjects with type 2 diabetes mellitus.
    Chang LH; Chang TT; Chu CH; Huang CC; Lin LY
    Clin Chim Acta; 2024 May; 558():117880. PubMed ID: 38555050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levels of Serum 25(OH)VD3, HIF-1α, VEGF, vWf, and IGF-1 and Their Correlation in Type 2 Diabetes Patients with Different Urine Albumin Creatinine Ratio.
    Shao Y; Lv C; Yuan Q; Wang Q
    J Diabetes Res; 2016; 2016():1925424. PubMed ID: 27069929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble CD36 in plasma and urine: a plausible prognostic marker for diabetic nephropathy.
    Shiju TM; Mohan V; Balasubramanyam M; Viswanathan P
    J Diabetes Complications; 2015 Apr; 29(3):400-6. PubMed ID: 25619588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the usefulness of plasma levels of oxidatively modified forms of albumin in estimating kidney dysfunction in diabetic patients.
    Piwowar A; Knapik-Kordecka M; Warwas M
    Clin Invest Med; 2010 Apr; 33(2):E109. PubMed ID: 20370990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intercellular adhesion molecule, plasma adiponectin and albuminuria in type 2 diabetic patients.
    Lenghel AR; Kacso IM; Bondor CI; Rusu C; Rahaian R; Gherman Caprioara M
    Diabetes Res Clin Pract; 2012 Jan; 95(1):55-61. PubMed ID: 21945031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-grade albuminuria is associated with early but not late carotid atherosclerotic lesions in community-based patients with type 2 diabetes.
    Li MF; Tu YF; Li LX; Lu JX; Dong XH; Yu LB; Zhang R; Bao YQ; Jia WP; Hu RM
    Cardiovasc Diabetol; 2013 Jul; 12():110. PubMed ID: 23883448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.